| Literature DB >> 21181417 |
A J Lederer1, H Bornemann-Cimenti, M Wejbora, C Kern-Pirsch, K Michaeli, A Sandner-Kiesling.
Abstract
Numerous studies support the theory that pregabalin causes an antihyperalgesic effect, which could be potentially beneficial in a perioperative setting. By binding to calcium channels pregabalin reduces the release of excitatory neurotransmitters and therefore inhibits central sensitization. Animal studies clearly demonstrated the antihyperalgesic potency of pregabalin but human experiments are, however, inconclusive. Clinical studies with quantitative sensory testing have not yet been published. Although strongly supported by theoretical considerations the routine preoperative application of pregabalin for the prevention of hyperalgesia cannot be recommended due to the lack of clinical studies. Future studies should incorporate secondary hyperalgesia and allodynia as primary parameters.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21181417 DOI: 10.1007/s00482-010-1008-x
Source DB: PubMed Journal: Schmerz ISSN: 0932-433X Impact factor: 1.107